The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment

J Crohns Colitis. 2019 Jul 25;13(7):956-957. doi: 10.1093/ecco-jcc/jjy219.

Authors

Christopher A Lamb^{1

2}, John C Mansfield^{1

2}, John A Kirby¹, Mary E Keir³

Affiliations

¹ Newcastle University, Newcastle upon Tyne, UK.
² Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
³ Genentech Inc., South San Francisco, CA, USA.

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized*
Biomarkers
Humans
Inflammatory Bowel Diseases*

Substances

Antibodies, Monoclonal, Humanized
Biomarkers
etrolizumab